Marginal Gains and Clinical Trials – Improving and Influencing Practice

por Gilbert, D.C., Henry, A.M., Choudhury, A.
Publicado 2022

Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2′-Deoxyzebularine Analogues

por Kvach, Maksim V., Barzak, Fareeda M., Harjes, Stefan, Schares, Henry A. M., Jameson, Geoffrey B., Ayoub, Alex M., Moorthy, Ramkumar, Aihara, Hideki, Harris, Reuben S., Filichev, Vyacheslav V., Harki, Daniel A., Harjes, Elena
Publicado 2018

Differential Inhibition of APOBEC3 DNA‐Mutator Isozymes by Fluoro‐ and Non‐Fluoro‐Substituted 2′‐Deoxyzebularine Embedded in Single‐Stranded DNA

por Kvach, Maksim V., Barzak, Fareeda M., Harjes, Stefan, Schares, Henry A. M., Kurup, Harikrishnan M., Jones, Katherine F., Sutton, Lorraine, Donahue, John, D'Aquila, Richard T., Jameson, Geoffrey B., Harki, Daniel A., Krause, Kurt L., Harjes, Elena, Filichev, Vyacheslav V.
Publicado 2019